Skip to main navigation Skip to search Skip to main content

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: Individual patient level meta-analysis of randomised controlled trials

  • Marco Valgimigli
  • , Felice Gragnano
  • , Mattia Branca
  • , Anna Franzone
  • , Usman Baber
  • , Yangsoo Jang
  • , Takeshi Kimura
  • , Joo Yong Hahn
  • , Qiang Zhao
  • , Stephan Windecker
  • , Charles M. Gibson
  • , Byeong Keuk Kim
  • , Hirotoshi Watanabe
  • , Young Bin Song
  • , Yunpeng Zhu
  • , Pascal Vranckx
  • , Shamir Mehta
  • , Sung Jin Hong
  • , Kenji Ando
  • , Hyeon Cheol Gwon
    • Patrick W. Serruys, George D. Dangas, Eùgene P. McFadden, Dominick J. Angiolillo, Dik Heg, Peter Jüni, Roxana Mehran
  • Cardiocentro Ticino Foundation
  • University of Bern
  • University of Campania Luigi Vanvitelli
  • University of Naples Federico II
  • Icahn School of Medicine at Mount Sinai
  • Yonsei University
  • Kyoto University
  • Shanghai Jiao Tong University
  • Beth Israel Deaconess Medical Center
  • Hartcentrum Hasselt
  • McMaster University
  • Hamilton Health Sciences
  • Kokura Memorial Hospital
  • University of Galway
  • Imperial College London
  • Cardialysis B.V.
  • University College Cork
  • University of Florida
  • University of Toronto

Research output: Contribution to journal › Article › peer-review

227   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: Individual patient level meta-analysis of randomised controlled trials'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science